APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pathogen mNGS Detection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pathogen mNGS Detection Market Outlook and Growth Opportunities 2026

12 August 2026199 pages

Choose your research edition.

Industry ResearchPathogen mNGS Detection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathogen mNGS Detection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pathogen mNGS Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathogen mNGS Detection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathogen mNGS Detection Market Analysis and Forecast 2026-2032175 pages · $4,950 USD

Market perspective

The global Pathogen mNGS Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pathogen mNGS Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pathogen mNGS Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pathogen mNGS Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pathogen mNGS Detection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pathogen mNGS Detection market include BGI Genomics, Guangzhou Kingmed Diagnostics Group, Guangzhou Weiyuan Gene Technology, Capitalbio, Beijing Golden Key Gene Technology, IngeniGen, Difei Medical Technology, WillingMed Technology and Hangzhou Matridx Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pathogen mNGS Detection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pathogen mNGS Detection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pathogen mNGS Detection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathogen mNGS Detection market.

Pathogen mNGS Detection Segment by Company

BGI Genomics

Guangzhou Kingmed Diagnostics Group

Guangzhou Weiyuan Gene Technology

Capitalbio

Beijing Golden Key Gene Technology

IngeniGen

Difei Medical Technology

WillingMed Technology

Hangzhou Matridx Biotechnology

Yuguo Biotechnology(Beijing)

Pathogen mNGS Detection Segment by Type

Technology Platform

Testing Service

Pathogen mNGS Detection Segment by Application

Hospital

Testing Facility

Other

Pathogen mNGS Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pathogen mNGS Detection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pathogen mNGS Detection key companies, revenue, market share, and recent developments.

3. To split the Pathogen mNGS Detection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pathogen mNGS Detection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pathogen mNGS Detection significant trends, drivers, influence factors in global and regions.

6. To analyze Pathogen mNGS Detection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathogen mNGS Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathogen mNGS Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathogen mNGS Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathogen mNGS Detection industry.

Chapter 3: Detailed analysis of Pathogen mNGS Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pathogen mNGS Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pathogen mNGS Detection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pathogen mNGS Detection Industry Trends Table 2. Pathogen mNGS Detection Industry Drivers Table 3. Pathogen mNGS Detection Industry Opportunities and Challenges Table 4. Pathogen mNGS Detection Industry Restraints Table 5. Global Pathogen mNGS Detection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pathogen mNGS Detection Revenue Share by Company (2021-2026) Table 7. Global Pathogen mNGS Detection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pathogen mNGS Detection Key Company Manufacturing Base & Headquarters Table 9. Global Pathogen mNGS Detection Company, Product Type & Application Table 10. Global Pathogen mNGS Detection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pathogen mNGS Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Technology Platform Table 15. Significant Companies of Testing Service Table 16. Global Pathogen mNGS Detection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pathogen mNGS Detection Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pathogen mNGS Detection Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pathogen mNGS Detection Sales Value Share by Type (2021-2026) Table 20. Global Pathogen mNGS Detection Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Testing Facility Table 23. Significant Companies of Other Table 24. Global Pathogen mNGS Detection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pathogen mNGS Detection Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pathogen mNGS Detection Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pathogen mNGS Detection Sales Value Share by Application (2021-2026) Table 28. Global Pathogen mNGS Detection Sales Value Share by Application (2027-2032) Table 29. Global Pathogen mNGS Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pathogen mNGS Detection Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pathogen mNGS Detection Sales Value Share by Region (2021-2026) Table 32. Global Pathogen mNGS Detection Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pathogen mNGS Detection Sales Value Share by Region (2027-2032) Table 34. Global Pathogen mNGS Detection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pathogen mNGS Detection Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pathogen mNGS Detection Sales Value Market Share by Country (2021-2026) Table 37. Global Pathogen mNGS Detection Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pathogen mNGS Detection Sales Value Market Share by Country (2027-2032) Table 39. BGI Genomics Company Information Table 40. BGI Genomics Business Overview Table 41. BGI Genomics Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. BGI Genomics Pathogen mNGS Detection Product Portfolio Table 43. BGI Genomics Recent Development Table 44. Guangzhou Kingmed Diagnostics Group Company Information Table 45. Guangzhou Kingmed Diagnostics Group Business Overview Table 46. Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Product Portfolio Table 48. Guangzhou Kingmed Diagnostics Group Recent Development Table 49. Guangzhou Weiyuan Gene Technology Company Information Table 50. Guangzhou Weiyuan Gene Technology Business Overview Table 51. Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Product Portfolio Table 53. Guangzhou Weiyuan Gene Technology Recent Development Table 54. Capitalbio Company Information Table 55. Capitalbio Business Overview Table 56. Capitalbio Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Capitalbio Pathogen mNGS Detection Product Portfolio Table 58. Capitalbio Recent Development Table 59. Beijing Golden Key Gene Technology Company Information Table 60. Beijing Golden Key Gene Technology Business Overview Table 61. Beijing Golden Key Gene Technology Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Beijing Golden Key Gene Technology Pathogen mNGS Detection Product Portfolio Table 63. Beijing Golden Key Gene Technology Recent Development Table 64. IngeniGen Company Information Table 65. IngeniGen Business Overview Table 66. IngeniGen Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. IngeniGen Pathogen mNGS Detection Product Portfolio Table 68. IngeniGen Recent Development Table 69. Difei Medical Technology Company Information Table 70. Difei Medical Technology Business Overview Table 71. Difei Medical Technology Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Difei Medical Technology Pathogen mNGS Detection Product Portfolio Table 73. Difei Medical Technology Recent Development Table 74. WillingMed Technology Company Information Table 75. WillingMed Technology Business Overview Table 76. WillingMed Technology Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. WillingMed Technology Pathogen mNGS Detection Product Portfolio Table 78. WillingMed Technology Recent Development Table 79. Hangzhou Matridx Biotechnology Company Information Table 80. Hangzhou Matridx Biotechnology Business Overview Table 81. Hangzhou Matridx Biotechnology Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Hangzhou Matridx Biotechnology Pathogen mNGS Detection Product Portfolio Table 83. Hangzhou Matridx Biotechnology Recent Development Table 84. Yuguo Biotechnology(Beijing) Company Information Table 85. Yuguo Biotechnology(Beijing) Business Overview Table 86. Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Product Portfolio Table 88. Yuguo Biotechnology(Beijing) Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Pathogen mNGS Detection Product Image Figure 2. Global Pathogen mNGS Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathogen mNGS Detection Market Size (2021-2032) & (US$ Million) Figure 4. Global Pathogen mNGS Detection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Technology Platform Image Figure 8. Testing Service Image Figure 9. Global Pathogen mNGS Detection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pathogen mNGS Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pathogen mNGS Detection Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Testing Facility Image Figure 14. Other Image Figure 15. Global Pathogen mNGS Detection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pathogen mNGS Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pathogen mNGS Detection Sales Value Share by Application (2021-2032) Figure 18. Global Pathogen mNGS Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pathogen mNGS Detection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pathogen mNGS Detection Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pathogen mNGS Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pathogen mNGS Detection Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pathogen mNGS Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pathogen mNGS Detection Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pathogen mNGS Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pathogen mNGS Detection Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pathogen mNGS Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pathogen mNGS Detection Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pathogen mNGS Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pathogen mNGS Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Technology Platform
  • Testing Service
Applications
  • Hospital
  • Testing Facility
  • Other
Companies covered
  • BGI Genomics
  • Guangzhou Kingmed Diagnostics Group
  • Guangzhou Weiyuan Gene Technology
  • Capitalbio
  • Beijing Golden Key Gene Technology
  • IngeniGen
  • Difei Medical Technology
  • WillingMed Technology
  • Hangzhou Matridx Biotechnology
  • Yuguo Biotechnology(Beijing)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pathogen mNGS Detection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pathogen mNGS Detection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pathogen mNGS Detection Market Dynamics
  1. 2.1 Pathogen mNGS Detection Industry Trends
  2. 2.2 Pathogen mNGS Detection Industry Drivers
  3. 2.3 Pathogen mNGS Detection Industry Opportunities and Challenges
  4. 2.4 Pathogen mNGS Detection Industry Restraints
3 Pathogen mNGS Detection Market by Company
  1. 3.1 Global Pathogen mNGS Detection Company Revenue Ranking in 2025
  2. 3.2 Global Pathogen mNGS Detection Revenue by Company (2021-2026)
  3. 3.3 Global Pathogen mNGS Detection Company Ranking (2024-2026)
  4. 3.4 Global Pathogen mNGS Detection Company Manufacturing Base and Headquarters
  5. 3.5 Global Pathogen mNGS Detection Company Product Type and Application
  6. 3.6 Global Pathogen mNGS Detection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pathogen mNGS Detection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pathogen mNGS Detection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pathogen mNGS Detection Market by Type
  1. 4.1 Pathogen mNGS Detection Type Introduction
  2. 4.1.1 Technology Platform
  3. 4.1.2 Testing Service
  4. 4.2 Global Pathogen mNGS Detection Sales Value by Type
  5. 4.2.1 Global Pathogen mNGS Detection Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pathogen mNGS Detection Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pathogen mNGS Detection Sales Value Share by Type (2021-2032)
5 Pathogen mNGS Detection Market by Application
  1. 5.1 Pathogen mNGS Detection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Testing Facility
  4. 5.1.3 Other
  5. 5.2 Global Pathogen mNGS Detection Sales Value by Application
  6. 5.2.1 Global Pathogen mNGS Detection Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pathogen mNGS Detection Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pathogen mNGS Detection Sales Value Share by Application (2021-2032)
6 Pathogen mNGS Detection Regional Value Analysis
  1. 6.1 Global Pathogen mNGS Detection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pathogen mNGS Detection Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pathogen mNGS Detection Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pathogen mNGS Detection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pathogen mNGS Detection Sales Value (2021-2032)
  7. 6.3.2 North America Pathogen mNGS Detection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pathogen mNGS Detection Sales Value (2021-2032)
  10. 6.4.2 Europe Pathogen mNGS Detection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pathogen mNGS Detection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pathogen mNGS Detection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pathogen mNGS Detection Sales Value (2021-2032)
  16. 6.6.2 South America Pathogen mNGS Detection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pathogen mNGS Detection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pathogen mNGS Detection Sales Value Share by Country, 2025 VS 2032
7 Pathogen mNGS Detection Country-level Value Analysis
  1. 7.1 Global Pathogen mNGS Detection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pathogen mNGS Detection Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pathogen mNGS Detection Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pathogen mNGS Detection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pathogen mNGS Detection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pathogen mNGS Detection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pathogen mNGS Detection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BGI Genomics
  2. 8.1.1 BGI Genomics Company Information
  3. 8.1.2 BGI Genomics Business Overview
  4. 8.1.3 BGI Genomics Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BGI Genomics Pathogen mNGS Detection Product Portfolio
  6. 8.1.5 BGI Genomics Recent Developments
  7. 8.2 Guangzhou Kingmed Diagnostics Group
  8. 8.2.1 Guangzhou Kingmed Diagnostics Group Company Information
  9. 8.2.2 Guangzhou Kingmed Diagnostics Group Business Overview
  10. 8.2.3 Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Product Portfolio
  12. 8.2.5 Guangzhou Kingmed Diagnostics Group Recent Developments
  13. 8.3 Guangzhou Weiyuan Gene Technology
  14. 8.3.1 Guangzhou Weiyuan Gene Technology Company Information
  15. 8.3.2 Guangzhou Weiyuan Gene Technology Business Overview
  16. 8.3.3 Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Product Portfolio
  18. 8.3.5 Guangzhou Weiyuan Gene Technology Recent Developments
  19. 8.4 Capitalbio
  20. 8.4.1 Capitalbio Company Information
  21. 8.4.2 Capitalbio Business Overview
  22. 8.4.3 Capitalbio Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Capitalbio Pathogen mNGS Detection Product Portfolio
  24. 8.4.5 Capitalbio Recent Developments
  25. 8.5 Beijing Golden Key Gene Technology
  26. 8.5.1 Beijing Golden Key Gene Technology Company Information
  27. 8.5.2 Beijing Golden Key Gene Technology Business Overview
  28. 8.5.3 Beijing Golden Key Gene Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Golden Key Gene Technology Pathogen mNGS Detection Product Portfolio
  30. 8.5.5 Beijing Golden Key Gene Technology Recent Developments
  31. 8.6 IngeniGen
  32. 8.6.1 IngeniGen Company Information
  33. 8.6.2 IngeniGen Business Overview
  34. 8.6.3 IngeniGen Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IngeniGen Pathogen mNGS Detection Product Portfolio
  36. 8.6.5 IngeniGen Recent Developments
  37. 8.7 Difei Medical Technology
  38. 8.7.1 Difei Medical Technology Company Information
  39. 8.7.2 Difei Medical Technology Business Overview
  40. 8.7.3 Difei Medical Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Difei Medical Technology Pathogen mNGS Detection Product Portfolio
  42. 8.7.5 Difei Medical Technology Recent Developments
  43. 8.8 WillingMed Technology
  44. 8.8.1 WillingMed Technology Company Information
  45. 8.8.2 WillingMed Technology Business Overview
  46. 8.8.3 WillingMed Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 WillingMed Technology Pathogen mNGS Detection Product Portfolio
  48. 8.8.5 WillingMed Technology Recent Developments
  49. 8.9 Hangzhou Matridx Biotechnology
  50. 8.9.1 Hangzhou Matridx Biotechnology Company Information
  51. 8.9.2 Hangzhou Matridx Biotechnology Business Overview
  52. 8.9.3 Hangzhou Matridx Biotechnology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hangzhou Matridx Biotechnology Pathogen mNGS Detection Product Portfolio
  54. 8.9.5 Hangzhou Matridx Biotechnology Recent Developments
  55. 8.10 Yuguo Biotechnology(Beijing)
  56. 8.10.1 Yuguo Biotechnology(Beijing) Company Information
  57. 8.10.2 Yuguo Biotechnology(Beijing) Business Overview
  58. 8.10.3 Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Product Portfolio
  60. 8.10.5 Yuguo Biotechnology(Beijing) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst